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Abstract
Chemokine receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Chemokine
Receptors [417, 416, 31]) comprise a large subfamily of 7TM proteins that bind one or more chemokines, a
large family of small cytokines typically possessing chemotactic activity for leukocytes. Additional hematopoietic
and non-hematopoietic roles have been identified for many chemokines in the areas of embryonic development,
immune cell proliferation, activation and death, viral infection, and as antibiotics, among others. Chemokine
receptors can be divided by function into two main groups: G protein-coupled chemokine receptors, which
mediate leukocyte trafficking, and "Atypical chemokine receptors", which may signal through non-G protein-
coupled mechanisms and act as chemokine scavengers to downregulate inflammation or shape chemokine
1
gradients [31].
Chemokines in turn can be divided by structure into four subclasses by the number and arrangement of
conserved cysteines. CC (also known as β-chemokines; n= 28), CXC (also known as α-chemokines; n= 17) and
CX3C (n= 1) chemokines all have four conserved cysteines, with zero, one and three amino acids separating
the first two cysteines respectively. C chemokines (n= 2) have only the second and fourth cysteines found in
other chemokines. Chemokines can also be classified by function into homeostatic and inflammatory subgroups.
Most chemokine receptors are able to bind multiple high-affinity chemokine ligands, but the ligands for a given
receptor are almost always restricted to the same structural subclass. Most chemokines bind to more than one
receptor subtype. Receptors for inflammatory chemokines are typically highly promiscuous with regard to ligand
specificity, and may lack a selective endogenous ligand. G protein-coupled chemokine receptors are named
acccording to the class of chemokines bound, whereas ACKR is the root acronym for atypical chemokine
receptors [32]. There can be substantial cross-species differences in the sequences of both chemokines and
chemokine receptors, and in the pharmacology and biology of chemokine receptors. Endogenous and microbial
non-chemokine ligands have also been identified for chemokine receptors. Many chemokine receptors function
as HIV co-receptors, but CCR5 is the only one demonstrated to play an essential role in HIV/AIDS
pathogenesis. The tables include both standard chemokine receptor names [657] and aliases.
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